Structured Review

Santa Cruz Biotechnology brain derived neurotrophic factor bdnf
List of primary antibodies used in this study
Brain Derived Neurotrophic Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brain derived neurotrophic factor bdnf/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
brain derived neurotrophic factor bdnf - by Bioz Stars, 2023-02
86/100 stars

Images

1) Product Images from "Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure"

Article Title: Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure

Journal: Molecular Vision

doi:

List of primary antibodies used in this study
Figure Legend Snippet: List of primary antibodies used in this study

Techniques Used: Concentration Assay, Derivative Assay

Fluorescent immunoreactivity of BDNF in control and glaucomatous retinas. Control retinas ( A and B ), and experimental glaucomatous retinas after one week ( C ) and five weeks ( D ) of elevated IOP. Abbreviations: brain derived neurotrophic factor (BDNF), ganglion cell layer (GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer plexiform layer (OPL). Scale bar equals 20 μm.
Figure Legend Snippet: Fluorescent immunoreactivity of BDNF in control and glaucomatous retinas. Control retinas ( A and B ), and experimental glaucomatous retinas after one week ( C ) and five weeks ( D ) of elevated IOP. Abbreviations: brain derived neurotrophic factor (BDNF), ganglion cell layer (GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer plexiform layer (OPL). Scale bar equals 20 μm.

Techniques Used: Derivative Assay


Structured Review

Santa Cruz Biotechnology rabbit anti brain derived neurotrophic factor
Rabbit Anti Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti brain derived neurotrophic factor/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rabbit anti brain derived neurotrophic factor - by Bioz Stars, 2023-02
86/100 stars

Images


Structured Review

Santa Cruz Biotechnology rabbit anti brain derived neurotrophic factor bdnf
PGC-1α induces hippocampal <t>BDNF</t> expression after chronic cerebral hypoperfusion. Representative images of brain sections immunostained for BDNF ( A, B ), and Western blots for BDNF ( C ) showed that BDNF protein was significantly downregulated in WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham group. By contrast, BDNF was up-regulated in the nPGC-1α+BCAS group. ( D, E ) Immunostaining in hippocampal CA1 area showed that there was only a downward trend for the numbers <t>of</t> <t>NeuN-positive</t> neurons in the WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham and nPGC-1α+BCAS groups. *p<0.05 as determined by one-way ANOVA. n = 5 in each group.
Rabbit Anti Brain Derived Neurotrophic Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti brain derived neurotrophic factor bdnf/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rabbit anti brain derived neurotrophic factor bdnf - by Bioz Stars, 2023-02
86/100 stars

Images

1) Product Images from "Upregulation of neuronal PGC-1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion"

Article Title: Upregulation of neuronal PGC-1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion

Journal: Theranostics

doi: 10.7150/thno.37119

PGC-1α induces hippocampal BDNF expression after chronic cerebral hypoperfusion. Representative images of brain sections immunostained for BDNF ( A, B ), and Western blots for BDNF ( C ) showed that BDNF protein was significantly downregulated in WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham group. By contrast, BDNF was up-regulated in the nPGC-1α+BCAS group. ( D, E ) Immunostaining in hippocampal CA1 area showed that there was only a downward trend for the numbers of NeuN-positive neurons in the WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham and nPGC-1α+BCAS groups. *p<0.05 as determined by one-way ANOVA. n = 5 in each group.
Figure Legend Snippet: PGC-1α induces hippocampal BDNF expression after chronic cerebral hypoperfusion. Representative images of brain sections immunostained for BDNF ( A, B ), and Western blots for BDNF ( C ) showed that BDNF protein was significantly downregulated in WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham group. By contrast, BDNF was up-regulated in the nPGC-1α+BCAS group. ( D, E ) Immunostaining in hippocampal CA1 area showed that there was only a downward trend for the numbers of NeuN-positive neurons in the WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham and nPGC-1α+BCAS groups. *p<0.05 as determined by one-way ANOVA. n = 5 in each group.

Techniques Used: Expressing, Western Blot, Immunostaining


Structured Review

Santa Cruz Biotechnology rabbit anti brain derived neurotrophic factor
Rabbit Anti Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti brain derived neurotrophic factor/product/Santa Cruz Biotechnology
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
rabbit anti brain derived neurotrophic factor - by Bioz Stars, 2023-02
86/100 stars

Images

rabbit monoclonal anti brain derived neurotrophic factor anti bdnf  (Santa Cruz Biotechnology)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Santa Cruz Biotechnology rabbit monoclonal anti brain derived neurotrophic factor anti bdnf
    The expression of Bcl-2 and <t>BDNF</t> was examined by immunohistochemistry. Notes: Signals of Bcl-2 ( A ) and BDNF ( B ) in hippocampus from different groups were analyzed by immunohistochemistry. Five high-powered fields were randomly chosen for analysis under 200× magnification using an inverted microscope. The positive cells were stained in brown or dark nankeen (marked with arrows). RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. The positive rate was quantified with ImageJ software by counting the average optical density. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, <t>brain-derived</t> <t>neurotrophic</t> factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.
    Rabbit Monoclonal Anti Brain Derived Neurotrophic Factor Anti Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti brain derived neurotrophic factor anti bdnf/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit monoclonal anti brain derived neurotrophic factor anti bdnf - by Bioz Stars, 2023-02
    86/100 stars

    Images

    1) Product Images from "Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats"

    Article Title: Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats

    Journal: Neuropsychiatric Disease and Treatment

    doi: 10.2147/NDT.S125088

    The expression of Bcl-2 and BDNF was examined by immunohistochemistry. Notes: Signals of Bcl-2 ( A ) and BDNF ( B ) in hippocampus from different groups were analyzed by immunohistochemistry. Five high-powered fields were randomly chosen for analysis under 200× magnification using an inverted microscope. The positive cells were stained in brown or dark nankeen (marked with arrows). RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. The positive rate was quantified with ImageJ software by counting the average optical density. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.
    Figure Legend Snippet: The expression of Bcl-2 and BDNF was examined by immunohistochemistry. Notes: Signals of Bcl-2 ( A ) and BDNF ( B ) in hippocampus from different groups were analyzed by immunohistochemistry. Five high-powered fields were randomly chosen for analysis under 200× magnification using an inverted microscope. The positive cells were stained in brown or dark nankeen (marked with arrows). RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. The positive rate was quantified with ImageJ software by counting the average optical density. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.

    Techniques Used: Expressing, Immunohistochemistry, Inverted Microscopy, Staining, Injection, Software, Derivative Assay

    The protein levels of Bcl-2 and BDNF from different groups were detected by western blot. Notes: ( A ) Rapamycin released the levels of Bcl-2 and BDNF suppressed by VPA exposure. Proteins of hippocampus were extracted for western blot. ( B ) Bands were quantified by using Quantity One software. RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. Compared with normal group, ** P <0.01; compared with ASD group, ## P <0.01. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.
    Figure Legend Snippet: The protein levels of Bcl-2 and BDNF from different groups were detected by western blot. Notes: ( A ) Rapamycin released the levels of Bcl-2 and BDNF suppressed by VPA exposure. Proteins of hippocampus were extracted for western blot. ( B ) Bands were quantified by using Quantity One software. RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. Compared with normal group, ** P <0.01; compared with ASD group, ## P <0.01. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.

    Techniques Used: Western Blot, Software, Injection, Derivative Assay


    Structured Review

    Santa Cruz Biotechnology anti brain derived neurotrophic factor bdnf
    Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, <t>BDNF,</t> <t>RAGE,</t> and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).
    Anti Brain Derived Neurotrophic Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti brain derived neurotrophic factor bdnf/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti brain derived neurotrophic factor bdnf - by Bioz Stars, 2023-02
    86/100 stars

    Images

    1) Product Images from "Sevoflurane Exacerbates Cognitive Impairment Induced by A β 1–40 in Rats through Initiating Neurotoxicity, Neuroinflammation, and Neuronal Apoptosis in Rat Hippocampus"

    Article Title: Sevoflurane Exacerbates Cognitive Impairment Induced by A β 1–40 in Rats through Initiating Neurotoxicity, Neuroinflammation, and Neuronal Apoptosis in Rat Hippocampus

    Journal: Mediators of Inflammation

    doi: 10.1155/2018/3802324

    Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, BDNF, RAGE, and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).
    Figure Legend Snippet: Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, BDNF, RAGE, and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).

    Techniques Used: Expressing, Western Blot


    Structured Review

    Santa Cruz Biotechnology rabbit anti brain derived neurotrophic factor
    Rabbit Anti Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti brain derived neurotrophic factor/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti brain derived neurotrophic factor - by Bioz Stars, 2023-02
    86/100 stars

    Images


    Structured Review

    Santa Cruz Biotechnology brain derived neurotrophic factor
    Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brain derived neurotrophic factor/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    brain derived neurotrophic factor - by Bioz Stars, 2023-02
    86/100 stars

    Images

    rabbit polyclonal anti brain derived neurotrophic factor  (Santa Cruz Biotechnology)

     
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Santa Cruz Biotechnology rabbit polyclonal anti brain derived neurotrophic factor
    Brain protein samples from rats subjected to MCAO for 30: Western blot results and corresponding densitometric analysis showed that the levels of <t>BDNF,</t> SYN and VEGF were increased in MCAO+Ex group compared with MCAO group; and that Nogo-A levels were reduced in the MCAO+Ex group. C: Correlation results showed that SYN levels were increased after exercise and were negatively correlated with Nogo-A levels in ischemic rat brain. Data are shown as mean ± S.E.M. * P <0.05 vs MCAO group; MCAO group (n = 4); MCAO+Ex group (n = 5).
    Rabbit Polyclonal Anti Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti brain derived neurotrophic factor/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit polyclonal anti brain derived neurotrophic factor - by Bioz Stars, 2023-02
    86/100 stars

    Images

    1) Product Images from "Exercise Promotes Axon Regeneration of Newborn Striatonigral and Corticonigral Projection Neurons in Rats after Ischemic Stroke"

    Article Title: Exercise Promotes Axon Regeneration of Newborn Striatonigral and Corticonigral Projection Neurons in Rats after Ischemic Stroke

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0080139

    Brain protein samples from rats subjected to MCAO for 30: Western blot results and corresponding densitometric analysis showed that the levels of BDNF, SYN and VEGF were increased in MCAO+Ex group compared with MCAO group; and that Nogo-A levels were reduced in the MCAO+Ex group. C: Correlation results showed that SYN levels were increased after exercise and were negatively correlated with Nogo-A levels in ischemic rat brain. Data are shown as mean ± S.E.M. * P <0.05 vs MCAO group; MCAO group (n = 4); MCAO+Ex group (n = 5).
    Figure Legend Snippet: Brain protein samples from rats subjected to MCAO for 30: Western blot results and corresponding densitometric analysis showed that the levels of BDNF, SYN and VEGF were increased in MCAO+Ex group compared with MCAO group; and that Nogo-A levels were reduced in the MCAO+Ex group. C: Correlation results showed that SYN levels were increased after exercise and were negatively correlated with Nogo-A levels in ischemic rat brain. Data are shown as mean ± S.E.M. * P <0.05 vs MCAO group; MCAO group (n = 4); MCAO+Ex group (n = 5).

    Techniques Used: Western Blot

    anti brain derived neurotrophic factor bdnf antibodies  (Santa Cruz Biotechnology)

     
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Santa Cruz Biotechnology anti brain derived neurotrophic factor bdnf antibodies
    Effect of GIN on the SCO-reduced protein expression of <t>BDNF</t> in the cortex. Mice were pretreated with GIN for 3 days before the start of the test and then continuously administered during the behavior tests. The protein expression ratios of BDNF/actin (a) <t>and</t> <t>p-Akt/Akt</t> (c) were monitored via western blot analysis. Data were presented as mean ± SEM ( n = 3). Significant difference between the groups: ∗ p < 0.05, vehicle-treated control versus SCO group; # p < 0.05, SCO alone group versus GIN-treated group in combination with SCO. (b) Effect of GIN on the activation of CREB via phosphorylation in the cortex was examined via immunohistochemistry by staining with anti-p-CREB antibody (right panel). (A) sham control, (B) SCO (1 mg/kg), (C) SCO (1 mg/kg) + GIN (10 mg/kg), (D) SCO (1 mg/kg) + GIN (25 mg/kg). The protein levels of p-CREB and CREB were also verified by western blot analysis (left panel).
    Anti Brain Derived Neurotrophic Factor Bdnf Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti brain derived neurotrophic factor bdnf antibodies/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti brain derived neurotrophic factor bdnf antibodies - by Bioz Stars, 2023-02
    86/100 stars

    Images

    1) Product Images from "Neuroprotective Effect and Molecular Mechanism of [6]-Gingerol against Scopolamine-Induced Amnesia in C57BL/6 Mice"

    Article Title: Neuroprotective Effect and Molecular Mechanism of [6]-Gingerol against Scopolamine-Induced Amnesia in C57BL/6 Mice

    Journal: Evidence-based Complementary and Alternative Medicine : eCAM

    doi: 10.1155/2018/8941564

    Effect of GIN on the SCO-reduced protein expression of BDNF in the cortex. Mice were pretreated with GIN for 3 days before the start of the test and then continuously administered during the behavior tests. The protein expression ratios of BDNF/actin (a) and p-Akt/Akt (c) were monitored via western blot analysis. Data were presented as mean ± SEM ( n = 3). Significant difference between the groups: ∗ p < 0.05, vehicle-treated control versus SCO group; # p < 0.05, SCO alone group versus GIN-treated group in combination with SCO. (b) Effect of GIN on the activation of CREB via phosphorylation in the cortex was examined via immunohistochemistry by staining with anti-p-CREB antibody (right panel). (A) sham control, (B) SCO (1 mg/kg), (C) SCO (1 mg/kg) + GIN (10 mg/kg), (D) SCO (1 mg/kg) + GIN (25 mg/kg). The protein levels of p-CREB and CREB were also verified by western blot analysis (left panel).
    Figure Legend Snippet: Effect of GIN on the SCO-reduced protein expression of BDNF in the cortex. Mice were pretreated with GIN for 3 days before the start of the test and then continuously administered during the behavior tests. The protein expression ratios of BDNF/actin (a) and p-Akt/Akt (c) were monitored via western blot analysis. Data were presented as mean ± SEM ( n = 3). Significant difference between the groups: ∗ p < 0.05, vehicle-treated control versus SCO group; # p < 0.05, SCO alone group versus GIN-treated group in combination with SCO. (b) Effect of GIN on the activation of CREB via phosphorylation in the cortex was examined via immunohistochemistry by staining with anti-p-CREB antibody (right panel). (A) sham control, (B) SCO (1 mg/kg), (C) SCO (1 mg/kg) + GIN (10 mg/kg), (D) SCO (1 mg/kg) + GIN (25 mg/kg). The protein levels of p-CREB and CREB were also verified by western blot analysis (left panel).

    Techniques Used: Expressing, Western Blot, Activation Assay, Immunohistochemistry, Staining

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    Santa Cruz Biotechnology brain derived neurotrophic factor bdnf
    List of primary antibodies used in this study
    Brain Derived Neurotrophic Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brain derived neurotrophic factor bdnf/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    brain derived neurotrophic factor bdnf - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology rabbit anti brain derived neurotrophic factor
    List of primary antibodies used in this study
    Rabbit Anti Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti brain derived neurotrophic factor/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti brain derived neurotrophic factor - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology rabbit anti brain derived neurotrophic factor bdnf
    PGC-1α induces hippocampal <t>BDNF</t> expression after chronic cerebral hypoperfusion. Representative images of brain sections immunostained for BDNF ( A, B ), and Western blots for BDNF ( C ) showed that BDNF protein was significantly downregulated in WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham group. By contrast, BDNF was up-regulated in the nPGC-1α+BCAS group. ( D, E ) Immunostaining in hippocampal CA1 area showed that there was only a downward trend for the numbers <t>of</t> <t>NeuN-positive</t> neurons in the WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham and nPGC-1α+BCAS groups. *p<0.05 as determined by one-way ANOVA. n = 5 in each group.
    Rabbit Anti Brain Derived Neurotrophic Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti brain derived neurotrophic factor bdnf/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti brain derived neurotrophic factor bdnf - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology rabbit monoclonal anti brain derived neurotrophic factor anti bdnf
    The expression of Bcl-2 and <t>BDNF</t> was examined by immunohistochemistry. Notes: Signals of Bcl-2 ( A ) and BDNF ( B ) in hippocampus from different groups were analyzed by immunohistochemistry. Five high-powered fields were randomly chosen for analysis under 200× magnification using an inverted microscope. The positive cells were stained in brown or dark nankeen (marked with arrows). RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. The positive rate was quantified with ImageJ software by counting the average optical density. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, <t>brain-derived</t> <t>neurotrophic</t> factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.
    Rabbit Monoclonal Anti Brain Derived Neurotrophic Factor Anti Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal anti brain derived neurotrophic factor anti bdnf/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit monoclonal anti brain derived neurotrophic factor anti bdnf - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology anti brain derived neurotrophic factor bdnf
    Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, <t>BDNF,</t> <t>RAGE,</t> and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).
    Anti Brain Derived Neurotrophic Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti brain derived neurotrophic factor bdnf/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti brain derived neurotrophic factor bdnf - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology brain derived neurotrophic factor
    Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, <t>BDNF,</t> <t>RAGE,</t> and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).
    Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/brain derived neurotrophic factor/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    brain derived neurotrophic factor - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology rabbit polyclonal anti brain derived neurotrophic factor
    Brain protein samples from rats subjected to MCAO for 30: Western blot results and corresponding densitometric analysis showed that the levels of <t>BDNF,</t> SYN and VEGF were increased in MCAO+Ex group compared with MCAO group; and that Nogo-A levels were reduced in the MCAO+Ex group. C: Correlation results showed that SYN levels were increased after exercise and were negatively correlated with Nogo-A levels in ischemic rat brain. Data are shown as mean ± S.E.M. * P <0.05 vs MCAO group; MCAO group (n = 4); MCAO+Ex group (n = 5).
    Rabbit Polyclonal Anti Brain Derived Neurotrophic Factor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti brain derived neurotrophic factor/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit polyclonal anti brain derived neurotrophic factor - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    86
    Santa Cruz Biotechnology anti brain derived neurotrophic factor bdnf antibodies
    Effect of GIN on the SCO-reduced protein expression of <t>BDNF</t> in the cortex. Mice were pretreated with GIN for 3 days before the start of the test and then continuously administered during the behavior tests. The protein expression ratios of BDNF/actin (a) <t>and</t> <t>p-Akt/Akt</t> (c) were monitored via western blot analysis. Data were presented as mean ± SEM ( n = 3). Significant difference between the groups: ∗ p < 0.05, vehicle-treated control versus SCO group; # p < 0.05, SCO alone group versus GIN-treated group in combination with SCO. (b) Effect of GIN on the activation of CREB via phosphorylation in the cortex was examined via immunohistochemistry by staining with anti-p-CREB antibody (right panel). (A) sham control, (B) SCO (1 mg/kg), (C) SCO (1 mg/kg) + GIN (10 mg/kg), (D) SCO (1 mg/kg) + GIN (25 mg/kg). The protein levels of p-CREB and CREB were also verified by western blot analysis (left panel).
    Anti Brain Derived Neurotrophic Factor Bdnf Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti brain derived neurotrophic factor bdnf antibodies/product/Santa Cruz Biotechnology
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti brain derived neurotrophic factor bdnf antibodies - by Bioz Stars, 2023-02
    86/100 stars
      Buy from Supplier

    Image Search Results


    List of primary antibodies used in this study

    Journal: Molecular Vision

    Article Title: Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure

    doi:

    Figure Lengend Snippet: List of primary antibodies used in this study

    Article Snippet: Brain Derived Neurotrophic Factor (BDNF) , Rabbit polyclonal , Santa Cruz, SC-546 , 1:500 , Amacrine cells and subpopulations of RGCs.

    Techniques: Concentration Assay, Derivative Assay

    Fluorescent immunoreactivity of BDNF in control and glaucomatous retinas. Control retinas ( A and B ), and experimental glaucomatous retinas after one week ( C ) and five weeks ( D ) of elevated IOP. Abbreviations: brain derived neurotrophic factor (BDNF), ganglion cell layer (GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer plexiform layer (OPL). Scale bar equals 20 μm.

    Journal: Molecular Vision

    Article Title: Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure

    doi:

    Figure Lengend Snippet: Fluorescent immunoreactivity of BDNF in control and glaucomatous retinas. Control retinas ( A and B ), and experimental glaucomatous retinas after one week ( C ) and five weeks ( D ) of elevated IOP. Abbreviations: brain derived neurotrophic factor (BDNF), ganglion cell layer (GCL), inner nuclear layer (INL), intraocular pressure (IOP), inner plexiform layer (IPL), outer nuclear layer (ONL), outer plexiform layer (OPL). Scale bar equals 20 μm.

    Article Snippet: Brain Derived Neurotrophic Factor (BDNF) , Rabbit polyclonal , Santa Cruz, SC-546 , 1:500 , Amacrine cells and subpopulations of RGCs.

    Techniques: Derivative Assay

    PGC-1α induces hippocampal BDNF expression after chronic cerebral hypoperfusion. Representative images of brain sections immunostained for BDNF ( A, B ), and Western blots for BDNF ( C ) showed that BDNF protein was significantly downregulated in WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham group. By contrast, BDNF was up-regulated in the nPGC-1α+BCAS group. ( D, E ) Immunostaining in hippocampal CA1 area showed that there was only a downward trend for the numbers of NeuN-positive neurons in the WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham and nPGC-1α+BCAS groups. *p<0.05 as determined by one-way ANOVA. n = 5 in each group.

    Journal: Theranostics

    Article Title: Upregulation of neuronal PGC-1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion

    doi: 10.7150/thno.37119

    Figure Lengend Snippet: PGC-1α induces hippocampal BDNF expression after chronic cerebral hypoperfusion. Representative images of brain sections immunostained for BDNF ( A, B ), and Western blots for BDNF ( C ) showed that BDNF protein was significantly downregulated in WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham group. By contrast, BDNF was up-regulated in the nPGC-1α+BCAS group. ( D, E ) Immunostaining in hippocampal CA1 area showed that there was only a downward trend for the numbers of NeuN-positive neurons in the WT+BCAS and PGC-1α f/f +BCAS groups compared to the sham and nPGC-1α+BCAS groups. *p<0.05 as determined by one-way ANOVA. n = 5 in each group.

    Article Snippet: After perforating with 0.2% Triton X-100 for 15 min, brain sections were blocked with 3% bovine serum albumin (BSA) for 30 min. Next, sections were incubated with the primary antibodies, including rabbit anti-brain-derived neurotrophic factor (BDNF) (1:500; Santa Cruz) and rabbit anti-neuron-specific DNA-binding protein (NeuN) (1:500; Abcam), overnight at 4°C.

    Techniques: Expressing, Western Blot, Immunostaining

    The expression of Bcl-2 and BDNF was examined by immunohistochemistry. Notes: Signals of Bcl-2 ( A ) and BDNF ( B ) in hippocampus from different groups were analyzed by immunohistochemistry. Five high-powered fields were randomly chosen for analysis under 200× magnification using an inverted microscope. The positive cells were stained in brown or dark nankeen (marked with arrows). RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. The positive rate was quantified with ImageJ software by counting the average optical density. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.

    Journal: Neuropsychiatric Disease and Treatment

    Article Title: Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats

    doi: 10.2147/NDT.S125088

    Figure Lengend Snippet: The expression of Bcl-2 and BDNF was examined by immunohistochemistry. Notes: Signals of Bcl-2 ( A ) and BDNF ( B ) in hippocampus from different groups were analyzed by immunohistochemistry. Five high-powered fields were randomly chosen for analysis under 200× magnification using an inverted microscope. The positive cells were stained in brown or dark nankeen (marked with arrows). RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. The positive rate was quantified with ImageJ software by counting the average optical density. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.

    Article Snippet: Rabbit monoclonal anti-brain-derived neurotrophic factor (anti-BDNF), B-cell lymphoma 2 (Bcl-2), and mouse monoclonal anti-GAPDH antibodies were purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA).

    Techniques: Expressing, Immunohistochemistry, Inverted Microscopy, Staining, Injection, Software, Derivative Assay

    The protein levels of Bcl-2 and BDNF from different groups were detected by western blot. Notes: ( A ) Rapamycin released the levels of Bcl-2 and BDNF suppressed by VPA exposure. Proteins of hippocampus were extracted for western blot. ( B ) Bands were quantified by using Quantity One software. RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. Compared with normal group, ** P <0.01; compared with ASD group, ## P <0.01. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.

    Journal: Neuropsychiatric Disease and Treatment

    Article Title: Rapamycin modulated brain-derived neurotrophic factor and B-cell lymphoma 2 to mitigate autism spectrum disorder in rats

    doi: 10.2147/NDT.S125088

    Figure Lengend Snippet: The protein levels of Bcl-2 and BDNF from different groups were detected by western blot. Notes: ( A ) Rapamycin released the levels of Bcl-2 and BDNF suppressed by VPA exposure. Proteins of hippocampus were extracted for western blot. ( B ) Bands were quantified by using Quantity One software. RAPA group, the offspring of control rats were administered with rapamycin; ASD + RAPA group, the offspring of VPA rats were injected with rapamycin. Compared with normal group, ** P <0.01; compared with ASD group, ## P <0.01. Abbreviations: Bcl-2, B-cell lymphoma 2; BDNF, brain-derived neurotrophic factor; VPA, valproic acid; RAPA, rapamycin; ASD, autism spectrum disorder.

    Article Snippet: Rabbit monoclonal anti-brain-derived neurotrophic factor (anti-BDNF), B-cell lymphoma 2 (Bcl-2), and mouse monoclonal anti-GAPDH antibodies were purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA).

    Techniques: Western Blot, Software, Injection, Derivative Assay

    Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, BDNF, RAGE, and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).

    Journal: Mediators of Inflammation

    Article Title: Sevoflurane Exacerbates Cognitive Impairment Induced by A β 1–40 in Rats through Initiating Neurotoxicity, Neuroinflammation, and Neuronal Apoptosis in Rat Hippocampus

    doi: 10.1155/2018/3802324

    Figure Lengend Snippet: Sevoflurane inhalation influenced protein expression of Bcl-xL, caspase-9, BDNF, RAGE, and mRNA level of IL-1 β , NF- κ B, and iNOS in the hippocampus. Caspase-9 (a, b), Bcl-xL (a, c), BDNF (d, e), and RAGE (d, f) protein levels in the NS- or A β -treated hippocampus of rats were determined using Western blot after inhaling 30% O 2 and 2.5% sevoflurane at the indicated times. Relative band intensity of each protein expression was calculated as % of the intensity of the β -actin protein band and expressed as a fold change in reference to their controls. IL-1 β (g), NF- κ B (h), and iNOS (i) mRNA levels in the NS- and A β -treated hippocampus were determined after inhaling 30% O 2 or 2.5% sevoflurane on day 7. The results were expressed as a fold change in reference to mRNA levels of their own controls. ∗ P < 0.05 vs. A β + O 2 ( n = 8); ∗∗ P < 0.01 vs. A β + O 2 ( n = 8).

    Article Snippet: The membrane was individually incubated with anti-GPAP (dilution, 1 : 500), anti-IBA1 (dilution, 1 : 5 00), anti-Bcl-xL (dilution, 1 : 1000), anti-caspase-9 (dilution, 1 : 2000), anti-receptor for advanced glycation end products (RAGE) (dilution, 1 : 1000) or anti-brain-derived neurotrophic factor (BDNF) (dilution, 1 : 1000) (Santa Cruz, CA), and β -actin (dilution, 1 : 500) (BioVision, US) as the primary antibodies at 4°C overnight and then incubated with horseradish peroxidase-conjugated secondary antibody (dilution, 1 : 2000) after washing with TBS.

    Techniques: Expressing, Western Blot

    Brain protein samples from rats subjected to MCAO for 30: Western blot results and corresponding densitometric analysis showed that the levels of BDNF, SYN and VEGF were increased in MCAO+Ex group compared with MCAO group; and that Nogo-A levels were reduced in the MCAO+Ex group. C: Correlation results showed that SYN levels were increased after exercise and were negatively correlated with Nogo-A levels in ischemic rat brain. Data are shown as mean ± S.E.M. * P <0.05 vs MCAO group; MCAO group (n = 4); MCAO+Ex group (n = 5).

    Journal: PLoS ONE

    Article Title: Exercise Promotes Axon Regeneration of Newborn Striatonigral and Corticonigral Projection Neurons in Rats after Ischemic Stroke

    doi: 10.1371/journal.pone.0080139

    Figure Lengend Snippet: Brain protein samples from rats subjected to MCAO for 30: Western blot results and corresponding densitometric analysis showed that the levels of BDNF, SYN and VEGF were increased in MCAO+Ex group compared with MCAO group; and that Nogo-A levels were reduced in the MCAO+Ex group. C: Correlation results showed that SYN levels were increased after exercise and were negatively correlated with Nogo-A levels in ischemic rat brain. Data are shown as mean ± S.E.M. * P <0.05 vs MCAO group; MCAO group (n = 4); MCAO+Ex group (n = 5).

    Article Snippet: The membranes were then blocked with 10% non-fat milk in Tris-HCl (10 mM, pH 7.4) containing 150 mM NaCl, and 1% Nonidet P-40, and separately incubated with the following specific antibodies at 4°C overnight: rabbit polyclonal anti-brain-derived neurotrophic factor (BDNF, Santa Cruz Biotechnology, Santa Cruz, CA, USA,1∶500 dilution), rabbit polyclonal anti-synapsin (SYN, Sigma, USA, 1∶1000), rabbit monoclonal anti-growth associated protein 43 (GAP43, Chemicon, Temecula, CA, USA, 1∶1000), mouse polyclonal anti-neurite growth inhibitor-A (Nogo-A, BD Transduction Laboratories, 1∶1000), rabbit polyclonal anti-vascular endothelial growth factor (VEGF, Santa Cruz 1∶500), goat polyclonal anti-glial fibrillary acidic protein (GFAP, Abcam, Cambridge, UK, 1∶2000), mouse monoclonal anti-tyrosine hydroxylase (TH, Sigma, 1∶1000), or mouse monoclonal anti-actin (Sigma, 1∶1000).

    Techniques: Western Blot

    Effect of GIN on the SCO-reduced protein expression of BDNF in the cortex. Mice were pretreated with GIN for 3 days before the start of the test and then continuously administered during the behavior tests. The protein expression ratios of BDNF/actin (a) and p-Akt/Akt (c) were monitored via western blot analysis. Data were presented as mean ± SEM ( n = 3). Significant difference between the groups: ∗ p < 0.05, vehicle-treated control versus SCO group; # p < 0.05, SCO alone group versus GIN-treated group in combination with SCO. (b) Effect of GIN on the activation of CREB via phosphorylation in the cortex was examined via immunohistochemistry by staining with anti-p-CREB antibody (right panel). (A) sham control, (B) SCO (1 mg/kg), (C) SCO (1 mg/kg) + GIN (10 mg/kg), (D) SCO (1 mg/kg) + GIN (25 mg/kg). The protein levels of p-CREB and CREB were also verified by western blot analysis (left panel).

    Journal: Evidence-based Complementary and Alternative Medicine : eCAM

    Article Title: Neuroprotective Effect and Molecular Mechanism of [6]-Gingerol against Scopolamine-Induced Amnesia in C57BL/6 Mice

    doi: 10.1155/2018/8941564

    Figure Lengend Snippet: Effect of GIN on the SCO-reduced protein expression of BDNF in the cortex. Mice were pretreated with GIN for 3 days before the start of the test and then continuously administered during the behavior tests. The protein expression ratios of BDNF/actin (a) and p-Akt/Akt (c) were monitored via western blot analysis. Data were presented as mean ± SEM ( n = 3). Significant difference between the groups: ∗ p < 0.05, vehicle-treated control versus SCO group; # p < 0.05, SCO alone group versus GIN-treated group in combination with SCO. (b) Effect of GIN on the activation of CREB via phosphorylation in the cortex was examined via immunohistochemistry by staining with anti-p-CREB antibody (right panel). (A) sham control, (B) SCO (1 mg/kg), (C) SCO (1 mg/kg) + GIN (10 mg/kg), (D) SCO (1 mg/kg) + GIN (25 mg/kg). The protein levels of p-CREB and CREB were also verified by western blot analysis (left panel).

    Article Snippet: Anti-Akt and anti-brain-derived neurotrophic factor (BDNF) antibodies were provided by Santa Cruz Biotechnology (CA, USA), and anti-actin antibody and other chemical reagents were bought from Sigma-Aldrich.

    Techniques: Expressing, Western Blot, Activation Assay, Immunohistochemistry, Staining